Low glutathione S-transferase P1 levels are associated with higher mortality in COVID-19 patients, and high levels of glutathione S-transferase P1 possibly offer protection for cellular redox reactions in severe COVID-19 infection, preventing deterioration especially in patients with co-morbidities like diabetes (Kumar D.S
The SUSTAIN-6 trial showed cardiovascular benefit, which expanded the label in 2020
This personalized support ensures you can continue your weight management journey comfortably and effectively
Key genetic mutations that cause a weakness in glutathione production are: CTH, GSTM1, GSTM3, GSTP1, AHCY-01, SOD2 and NAT2
Independent Third-Party Verification on Every Batch Release sign-off rests with a separately operated laboratory accredited to the ISO/IEC 17025 international standard for testing competence
Chung, Pranabananda Dutta, Nathaniel Chard, Yong Wu, Qiao-Hong Chen, Guanglin Chen, Jaydutt Vadgama Oncotarget.2019